Acute Effects of Moderate-Intensity Continuous Exercise Versus HIIT on Cognitive Performance and Psychophysiological Responses in Physically Active Adults (EXCOG)

February 6, 2026 updated by: Maged Basha, Qassim University

Acute Effects of Moderate-Intensity Continuous Exercise Versus High-Intensity Interval Training on Cognitive Performance and Psychophysiological Responses in Physically Active Adults: A Randomized Crossover Study

This study aims to compare the immediate effects of two common types of exercise-moderate-intensity continuous exercise and high-intensity interval training (HIIT)-on attention, alertness, and physiological responses in physically active young adults.

Attention and mental alertness are essential for learning, academic performance, and daily functioning. Previous research suggests that a single session of exercise can temporarily improve cognitive performance, but it is not clear whether moderate exercise or high-intensity interval exercise is more effective in producing these immediate benefits.

In this study, participants will complete two supervised treadmill exercise sessions on separate days: one session of moderate-intensity continuous exercise and one session of high-intensity interval training. The order of the two exercise sessions will be randomized, and there will be a rest period of 48 to 72 hours between sessions.

Before and immediately after each exercise session, participants will complete computerized cognitive tests that measure sustained attention and reaction time. Heart rate, oxygen saturation, perceived exertion, mood, and alertness will also be measured to evaluate physiological and psychological responses to exercise.

By comparing the effects of these two exercise approaches within the same individuals, this study aims to identify which type of exercise leads to better immediate cognitive performance and favorable physiological responses. The findings may help guide exercise recommendations for improving attention, alertness, and overall mental performance in young adults.

Study Overview

Detailed Description

This study is a randomized within-subject crossover clinical trial designed to compare the acute effects of moderate-intensity continuous exercise (MICE) and high-intensity interval training (HIIT) on cognitive performance and psychophysiological responses in physically active young adults.

Each participant will complete two supervised treadmill exercise sessions-one MICE session and one HIIT session-on separate days, with a 48-72-hour washout period. The order of the two exercise conditions will be randomized using a computer-generated sequence. This crossover design allows each participant to serve as their own control, reducing inter-individual variability and increasing statistical power.

Cognitive performance will be assessed immediately before and after each exercise session using validated computerized tests of sustained attention and vigilance, including the Sustained Attention to Response Task (SART) and the Psychomotor Vigilance Task (PVT). Primary cognitive outcomes will include reaction time, accuracy, response inhibition, and attentional lapses.

Psychophysiological responses will be monitored throughout the exercise sessions and immediately post-exercise. These include heart rate, oxygen saturation, rating of perceived exertion, mood, and alertness. Exercise intensity will be prescribed based on percentages of age-predicted maximum heart rate and continuously monitored to ensure protocol adherence and participant safety.

Data will be analyzed using within-subject statistical comparisons to evaluate differences between exercise conditions. The findings are expected to provide evidence on how acute exercise intensity influences immediate cognitive and physiological responses, informing exercise recommendations for optimizing attention and alertness in young adults.

Study Type

Interventional

Enrollment (Estimated)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Al-Qassim Region
      • Buraidah, Al-Qassim Region, Saudi Arabia, 2100
        • Qassim University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Aged between 18 and 30 years.
  • Physically active individuals, as assessed by the International Physical Activity Questionnaire (IPAQ).
  • In good general health.
  • Cleared for physical activity participation based on the Physical Activity Readiness Questionnaire (PAR-Q).
  • Enrolled as university students.
  • Able and willing to provide written informed consent.

Exclusion Criteria:

  • History of cardiovascular, neurological, or musculoskeletal disorders that may affect exercise safety or cognitive performance.
  • Presence of uncontrolled hypertension, recent concussion, or any medical condition contraindicating exercise.
  • Use of medications that may influence cognition, mood, or cardiovascular responses.
  • Pregnancy.
  • Failure to pass PAR-Q screening without medical clearance.
  • Heavy smoking or history of substance abuse.
  • Visual or hearing impairments that could interfere with computerized cognitive task performance.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Moderate-Intensity Continuous Exercise (MICE)
Participants perform continuous treadmill exercise for 20 minutes at 60-70% of age-predicted maximum heart rate, including standardized warm-up and cool-down periods. Heart rate, oxygen saturation, and perceived exertion are monitored throughout the session to ensure protocol adherence and participant safety.
Participants perform continuous treadmill exercise for 20 minutes at 60-70% of age-predicted maximum heart rate. Each session includes a standardized warm-up period of approximately 3 minutes and a cool-down period of 2-3 minutes. Heart rate, oxygen saturation, and rating of perceived exertion are monitored throughout the session to ensure adherence to the target intensity and participant safety.
Other Names:
  • Moderate Aerobic Exercise
  • Continuous Aerobic Exercise
Experimental: High-Intensity Interval Training (HIIT)
Participants perform treadmill-based high-intensity interval training consisting of repeated short bouts at 85-95% of age-predicted maximum heart rate interspersed with brief recovery periods, with a total session duration of approximately 20 minutes including warm-up and cool-down. Heart rate, oxygen saturation, and perceived exertion are continuously monitored.
Participants perform treadmill-based high-intensity interval training consisting of repeated short bouts of exercise at 85-95% of age-predicted maximum heart rate, interspersed with brief recovery periods. Total session duration is approximately 20 minutes, including standardized warm-up and cool-down periods. Heart rate, oxygen saturation, and rating of perceived exertion are continuously monitored to ensure safety and protocol compliance.
Other Names:
  • High-Intensity Interval Exercise
  • Interval Aerobic Training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sustained Attention to Response Task (SART) Performance
Time Frame: Immediately before each exercise session (within the same day for both intervention conditions)
Sustained attention and response inhibition will be assessed using the Sustained Attention to Response Task (SART). Outcome variables will include reaction time, accuracy, commission errors, and omission errors, reflecting participants' ability to maintain sustained attention and inhibitory control following acute exercise.
Immediately before each exercise session (within the same day for both intervention conditions)
Sustained Attention to Response Task (SART) Performance
Time Frame: immediately after each exercise session (within the same day for both intervention conditions)
Sustained attention and response inhibition will be assessed using the Sustained Attention to Response Task (SART). Outcome variables will include reaction time, accuracy, commission errors, and omission errors, reflecting participants' ability to maintain sustained attention and inhibitory control following acute exercise.
immediately after each exercise session (within the same day for both intervention conditions)
Psychomotor Vigilance Task (PVT) Performance
Time Frame: Immediately before each exercise session (within the same day for both intervention conditions)
Vigilance and reaction time will be evaluated using the Psychomotor Vigilance Task (PVT). Outcome variables will include mean reaction time, number of attentional lapses, and response accuracy, reflecting participants' sustained alertness following acute exercise.
Immediately before each exercise session (within the same day for both intervention conditions)
Psychomotor Vigilance Task (PVT) Performance
Time Frame: immediately after each exercise session (within the same day for both intervention conditions)
Vigilance and reaction time will be evaluated using the Psychomotor Vigilance Task (PVT). Outcome variables will include mean reaction time, number of attentional lapses, and response accuracy, reflecting participants' sustained alertness following acute exercise.
immediately after each exercise session (within the same day for both intervention conditions)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate Response During and After Exercise
Time Frame: During each exercise session
Heart rate will be continuously monitored during each exercise session and recorded at baseline, during exercise, and immediately post-exercise to evaluate physiological responses to moderate-intensity continuous exercise and high-intensity interval training.
During each exercise session
Heart Rate Response During and After Exercise
Time Frame: Immediately after each exercise session
Heart rate will be continuously monitored during each exercise session and recorded at baseline, during exercise, and immediately post-exercise to evaluate physiological responses to moderate-intensity continuous exercise and high-intensity interval training.
Immediately after each exercise session
Oxygen Saturation (SpO₂) Response
Time Frame: During each exercise session
Peripheral oxygen saturation will be measured using a pulse oximeter before, during, and immediately after each exercise session to assess acute cardiorespiratory responses to exercise intensity.
During each exercise session
Oxygen Saturation (SpO₂) Response
Time Frame: Immediately after each exercise session
Peripheral oxygen saturation will be measured using a pulse oximeter before, during, and immediately after each exercise session to assess acute cardiorespiratory responses to exercise intensity.
Immediately after each exercise session
Rating of Perceived Exertion Assessed by the Borg Rating of Perceived Exertion Scale (6-20)
Time Frame: During each exercise session
Perceived exertion will be assessed using the Borg Rating of Perceived Exertion (RPE) Scale (6-20) during and immediately after each exercise session to evaluate subjective exercise intensity and effort. The scale ranges from 6 (no exertion at all) to 20 (maximal exertion). Higher scores indicate greater perceived physical effort.
During each exercise session
Rating of Perceived Exertion Assessed by the Borg Rating of Perceived Exertion Scale (6-20)
Time Frame: Immediately after each exercise session
Perceived exertion will be assessed using the Borg Rating of Perceived Exertion (RPE) Scale (6-20) during and immediately after each exercise session to evaluate subjective exercise intensity and effort. The scale ranges from 6 (no exertion at all) to 20 (maximal exertion). Higher scores indicate greater perceived physical effort.
Immediately after each exercise session
Mood and Alertness Assessed by Numeric Rating Scales (0-10)
Time Frame: Immediately before each exercise session
Subjective mood and alertness will be assessed using separate 10-point Numeric Rating Scales (0-10) administered immediately before and immediately after each exercise session. For each scale, 0 represents the lowest level (very poor mood / extremely sleepy) and 10 represents the highest level (excellent mood / fully alert). Higher scores indicate better mood and greater alertness.
Immediately before each exercise session
Mood and Alertness Assessed by Numeric Rating Scales (0-10)
Time Frame: Immediately after each exercise session
Subjective mood and alertness will be assessed using separate 10-point Numeric Rating Scales (0-10) administered immediately before and immediately after each exercise session. For each scale, 0 represents the lowest level (very poor mood / extremely sleepy) and 10 represents the highest level (excellent mood / fully alert). Higher scores indicate better mood and greater alertness.
Immediately after each exercise session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2025

Primary Completion (Estimated)

March 1, 2026

Study Completion (Estimated)

April 5, 2026

Study Registration Dates

First Submitted

January 30, 2026

First Submitted That Met QC Criteria

February 6, 2026

First Posted (Actual)

February 10, 2026

Study Record Updates

Last Update Posted (Actual)

February 10, 2026

Last Update Submitted That Met QC Criteria

February 6, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared publicly. All collected data will be analyzed and reported in aggregate form only to ensure participant confidentiality and data protection.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Performance

Clinical Trials on Moderate-Intensity Continuous Exercise (MICE)

Subscribe